In the T2D subjects of the same study (91% remission rate at 2 years post-surgery), both disposition indices and insulin secretion in response to intravenously administered glucose improve 2 years post-surgery but are still notably lower than population norms. The gene discussed is INS; the disease is type 2 diabetes mellitus.